Surrogate end points in cancer research: a critique.

No abstract is available for this paper.

• Publication year

  1996

• Venue

  Cancer Epidemiology, Biomarkers and Prevention

• Publication date

  1996-12-01

• Fields of study

  Medicine

• Identifiers
  PMID 8959315
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Relation of prediagnostic serum estrogen and androgen levels to breast cancer risk.

  1996cited by this paper
• The polyp prevention trial I: rationale, design, recruitment, and baseline participant characteristics.

  1996cited by this paper
• Comparison of proliferating cell nuclear antigen versus the more standard measures of rectal mucosal proliferation rates in subjects with a history of colorectal cancer and normal age-matched controls.

  1995cited by this paper
• A prospective study of endogenous estrogens and breast cancer in postmenopausal women.

  1995cited by this paper
• Reproducibility of plasma hormone levels in postmenopausal women over a 2-3-year period.

  1995cited by this paper
• Epidemiological use of rectal proliferation measures.

  1995cited by this paper
• Inhibition of apoptosis during development of colorectal cancer.

  1995cited by this paper
• Screening for ovarian cancer: What are the optimal surrogate endpoints for clinical trials?

  1995cited by this paper
• Reliability of measurements of total, protein-bound, and unbound estradiol in serum.

  1994cited by this paper
• Reproducibility and variability of the rectal mucosal proliferation index using proliferating cell nuclear antigen immunohistochemistry.

  1994cited by this paper
• Molecular biomarkers for aflatoxins and their application to human cancer prevention.

  1994cited by this paper
• Is Helicobacter pylori a cause of gastric cancer? An appraisal of the seroepidemiological evidence.

  1994cited by this paper
• Barrett's esophagus, dysplasia, and adenocarcinoma.

  1994cited by this paper
• Chemoprevention of oral cancer: beta-carotene and vitamin E in leukoplakia.

  1994cited by this paper
• Test reliability is critically important to molecular epidemiology: an example from studies of human papillomavirus infection and cervical neoplasia.

  1994cited by this paper
• The natural history of cervical intraepithelial neoplasia: an argument for intermediate endpoint biomarkers.

  1994cited by this paper
• Interpreting precursor studies: what polyp trials tell us about large-bowel cancer.

  1994cited by this paper
• Restoration of squamous mucosa after ablation of Barrett's esophageal epithelium.

  1993cited by this paper
• Epidemiologic evidence showing that human papillomavirus infection causes most cervical intraepithelial neoplasia.

  1993cited by this paper
• Mammographic parenchymal patterns: a marker of breast cancer risk.

  1993cited by this paper
• Clinical experience with the micronucleus assay

  1993cited by this paper
• In vitro protective effects of chemopreventive agents against bleomycin-induced genotoxicity in lymphoblastoid cell lines and peripheral blood lymphocytes of head and neck cancer patients.

  1993cited by this paper
• Effects of alcohol consumption on plasma and urinary hormone concentrations in premenopausal women.

  1993cited by this paper
• Statistical validation of intermediate endpoints for chronic diseases.

  1992cited by this paper
• Recent progress in defining the epidemiology of human papillomavirus infection and cervical neoplasia.

  1992cited by this paper
• Genetic alterations in the adenoma–carcinoma sequence

  1992cited by this paper
• Nutrition and cancer: background and rationale of the European Prospective Investigation into Cancer and Nutrition (EPIC).

  1992cited by this paper
• Sample size for studying intermediate endpoints within intervention trails or observational studies.

  1992cited by this paper
• Genetic alterations underlying colorectal tumorigenesis.

  1992cited by this paper
• From adenoma to carcinoma of the colorectum.

  1991cited by this paper
• Reliability and interrelations among serum sex hormones in postmenopausal women.

  1991cited by this paper
• Validation of intermediate end points in cancer research.

  1990cited by this paper
• Dietary fat reduction and plasma estradiol concentration in healthy postmenopausal women. The Women's Health Trial Study Group.

  1990cited by this paper
• Neoplastic transformation of a human colonic epithelial cell line: in vitro evidence for the adenoma to carcinoma sequence.

  1990cited by this paper
• Surrogate endpoints in clinical trials: definition and operational criteria.

  1989cited by this paper
• A human model of gastric carcinogenesis.

  1988cited by this paper
• The design and analysis of clinical experiments

  1987cited by this paper
• Regression of bronchial epidermoid metaplasia in heavy smokers with etretinate treatment.

  1986cited by this paper
• Regression of bronchial epidermoid metaplasia in heavy smokers with etretinate treatment.

  1985cited by this paper
• Seventh-Day Adventist vegetarians have a quiescent proliferative activity in colonic mucosa.

  1985cited by this paper
• Classification and risk assessment of individuals with familial polyposis, Gardner's syndrome, and familial non-polyposis colon cancer from [3H]thymidine labeling patterns in colonic epithelial cells.

  1984cited by this paper
• Hypomethylation distinguishes genes of some human cancers from their normal counterparts

  1983cited by this paper
• The evolution of cancer of the colon and rectum

  1975cited by this paper

• The Infection Status and Distribution of hrHPV in Cervical Lesions Among Overweight Women Referred for Colposcopy: A Cross-Sectional Study

  2025cites this paper
• Considerations for using potential surrogate endpoints in cancer screening trials

  2024cites this paper
• Epidemiologic Evidence That Excess Body Weight Increases Risk of Cervical Cancer by Decreased Detection of Precancer.

  2018cites this paper
• Early Life Exposures and Adult Cancer Risk

  2017cites this paper
• Prognostic Significance of VEGF after Twenty-Year Follow-up in a Randomized Trial of Fenretinide in Non–Muscle-Invasive Bladder Cancer

  2016cites this paper
• NUTRIENTS AND GASTROINTESTINAL MALIGNANCIES Diet and Upper Gastrointestinal Malignancies

  2015cites this paper
• Diet and upper gastrointestinal malignancies.

  2015cites this paper
• Implications of the Institute of Medicine Report: Evaluation of Biomarkers and Surrogate Endpoints in Chronic Disease

  2015cites this paper
• C URRENT OPINION Meaningful end points and outcomes in men on active surveillance for early-stage prostate cancer

  2014cites this paper
• Meaningful end points and outcomes in men on active surveillance for early-stage prostate cancer

  2014cites this paper
• Correlates of vaccine-induced protection: methods and implications

  2013cites this paper
• Phase III Trial of Selenium to Prevent Prostate Cancer in Men with High-grade Prostatic Intraepithelial Neoplasia : SWOG S 9917

  2011cites this paper
• Perspective of clinical research in follicular NHL: interaction between science and industry.

  2011cites this paper
• Phase III Trial of Selenium to Prevent Prostate Cancer in Men with High-grade Prostatic Intraepithelial Neoplasia: SWOG S9917

  2011cites this paper
• Impact of improved classification on the association of human papillomavirus with cervical precancer.

  2010cites this paper
• Evaluation of Biomarkers and Surrogate Endpoints in Chronic Disease

  2010cites this paper
• Vegetables, fruits, and colorectal cancer risk: what should we believe?

  2009cites this paper
• Measuring the Impact of Nutrition Education and Physical Activity on Older Adults Participating in Government Sponsored Programs

  2009cites this paper
• Terpenoids and breast cancer chemoprevention

  2009cites this paper
• Health services research.

  2008cites this paper
• Intermediacy and gene-environment interaction: the example of CHRNA5-A3 region, smoking, nicotine dependence, and lung cancer.

  2008cites this paper
• Dietary terpenoids and prostate cancer chemoprevention.

  2008cites this paper
• Mouse Models for Gastrointestinal Cancer

  2007cites this paper
• Prognostic Effect of DNA Aneuploidy from Bladder Washings in Superficial Bladder Cancer

  2007cites this paper
• Celecoxib Decreases Ki-67 Proliferative Index in Active Smokers

  2006cites this paper
• Inherited Cancer Syndromes: Research Roundup

  2006cites this paper
• Issues in the design and analysis of clinical trials with time-to-event outcomes.

  2006cites this paper
• Chronic cigarette smoking is associated with diminished folate status, altered folate form distribution, and increased genetic damage in the buccal mucosa of healthy adults.

  2006cites this paper
• Relationship of nutrients and food to colorectal cancer risk in Koreans

  2005cites this paper
• The Mediation Proportion: A Structural Equation Approach for Estimating the Proportion of Exposure Effect on Outcome Explained by an Intermediate Variable

  2005cites this paper
• The use of biomarkers in surveillance, medical screening, and intervention.

  2005cites this paper
• Designing a Randomized Phase I/II Prostate Cancer Chemoprevention Trial Using 1α‐Hydroxy‐24‐Ethyl‐Cholecalciferol, an Analogue of Vitamin D3

  2004cites this paper
• Inherited Cancer Syndromes

  2004cites this paper
• Breast Cancer Genetics

  2004cites this paper
• Appropriate models and an understanding of carcinogenic mechanisms--requirements for hazard risk assessment.

  2003cites this paper
• Transforming growth factor-alpha: a surrogate endpoint biomarker?

  2002cites this paper
• Primary prevention: phytoprevention and chemoprevention of colorectal cancer.

  2002cites this paper
• Transforming growth factor-α: a surrogate endpoint biomarker?1

  2002cites this paper
• Confidence intervals and statistical power of the ‘Validation’ ratio for surrogate or intermediate endpoints

  2001cites this paper
• Validation of surrogate endpoint biomarkers in prostate cancer chemoprevention trials.

  2001cites this paper
• Statistical methods in cancer research

  2001cites this paper
• Effects of folate supplementation on two provisional molecular markers of colon cancer: a prospective, randomized trial

  2001influential citation
• Risk Estimation Based on Chromosomal Aberrations Induced by Radiation

  2001cites this paper
• Randomized trial of fenretinide in superficial bladder cancer using DNA flow cytometry as an intermediate end point.

  2000cites this paper
• Biomarkers as surrogates for cancer development

  2000cites this paper
• Primary cancer prevention trials.

  2000cites this paper
• AGA technical review: impact of dietary fiber on colon cancer occurrence.

  2000cites this paper
• Marriage of Surrogate Markers with Medium Term Tests for Carcinogenicity and Modification Potential.

  2000cites this paper
• Benign Breast Tissue Sampling for Prevention Studies

  2000cites this paper
• Ensuring Quality Cancer Care

  1999cites this paper
• Evaluation of Biomarker Modulation by Fenretinide in Prostate Cancer Patients

  1999cites this paper
• Studies of Calcium in Food Supplements in Humans

  1999cites this paper
• Marriage of a medium-term liver model to surrogate markers--a practical approach for risk and benefit assessment.

  1999cites this paper
• Combining environmental exposure and genetic effect measurements in health outcome assessment.

  1999cites this paper
• An evaluation of rectal mucosal proliferation measure variability sources in the polyp prevention trial: can we detect informative differences among individuals' proliferation measures amid the noise?

  1998cites this paper
• Models for early chemoprevention trials in breast cancer.

  1998cites this paper
• Rectal epithelial proliferation in persons with or without a history of adenoma and its association with diet and lifestyle habits

  1998cites this paper
• Rectal mucosal proliferation, dietary factors, and the risk of colorectal adenomas.

  1998cites this paper
• Chronically elevated proliferation as a risk factor for neoplasia.

  1998cites this paper
• Serum autoantibodies recognizing 5-hydroxymethyl-2'-deoxyuridine, an oxidized DNA base, as biomarkers of cancer risk in women.

  1998cites this paper
• Cancer chemoprevention: progress and promise.

  1998cites this paper
• Folate and colon cancer: a fascinating puzzle we have yet to complete.

  1998cites this paper
• ASSESSMENT OF THE QUALITY OF CANCER CARE: A REVIEW FOR THE NATIONAL CANCER POLICY BOARD OF THE INSTITUTE OF MEDICINE

  1998cites this paper
• Dietary change as a strategy for preventing cancer

  1997cites this paper
• DNA Damage as an Intermediate Biomarker in Intervention Studies

  1997cites this paper
• GASTROENTEROLOGY CLINICS OF NORTH AMERICA Prevention of Colorectal Cancer : Diet , Chemoprevention , and Lifestyle

  year unknowncites this paper